Primary Cutaneous Lymphomas and Interferon Treatment
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 001-010
- https://doi.org/10.29328/journal.jhcr.1001001
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypePLOS ONE, 2013
- Clinical Trials of Adult T-Cell Leukaemia/Lymphoma TreatmentLeukemia Research and Treatment, 2012
- Imprint cytology facilitating the diagnosis of primary cutaneous anaplastic large cell lymphoma of iliac fossaJournal of Cytology, 2012
- EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*Blood, 2011
- Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerJournal of Clinical Oncology, 2011
- Interferon lambdas: the next cytokine stormGut, 2011
- Borrelia burgdorferi—associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2aJournal of the American Academy of Dermatology, 1997
- Complete remission of a primary cutaneous B cell lymphoma treated with intralesional recombinant interferon alpha-2aEuropean Journal of Cancer, 1994
- Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoidsJournal of the American Academy of Dermatology, 1991
- Sézary syndrome: Diagnosis, prognosis, and critical review of treatment optionsJournal of the American Academy of Dermatology, 1990